HISTORY

For more than 30 years, Janssen Biotech, Inc. has delivered on the promise of new treatments and new ways to improve the health of individuals with serious disease.

Built upon a rich legacy of innovative "firsts," Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, and nephrology. With the same unwavering passion for new challenges, we dedicate ourselves to delivering solutions for these disease states where unmet needs continue to exist.

Rooted in rich scientific collaborations and community-based relationships, we have access to some of the top minds in science today, allowing us to advance the treatment of patients through our innovative medicines. Our discoveries lead us not only to new treatments, but also to new ways to empower patients and expand their access to quality care–because we believe that changing lives for the better takes more than medicine.

Janssen Biotech, Inc. is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. We invite you to visit our sister companies, Janssen Pharmaceuticals, Inc. and Janssen Therapeutics, who share our vision of advancing patient care.